Amylyx Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Amylyx Pharmaceuticals, Inc. has filed 414 SEC EDGAR filings since 17 Nov 2015

SEC filing history

Showing 251-275 of 414 matching filings.

Per page
25
Current page
11
SC 13G File 005-93265

SC 13G filing

Filing date
09 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
24 May 2023
Reporting date
22 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 May 2023
Reporting date
17 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2023
Reporting date
16 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 May 2023
Reporting date
15 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41199

144 filing

Filing date
16 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41199

144 filing

Filing date
15 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-41199

ARS

Filing date
27 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41199

DEFA14A

Filing date
27 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41199

DEF 14A

Filing date
27 Apr 2023
Reporting date
08 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
26 Apr 2023
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
26 Apr 2023
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Apr 2023
Reporting date
17 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41199

144 filing

Filing date
17 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-93265

SC 13D/A

Filing date
03 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Mar 2023
Reporting date
29 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Mar 2023
Reporting date
27 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
24 Mar 2023
Reporting date
16 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
24 Mar 2023
Reporting date
16 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Mar 2023
Reporting date
21 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2023
Reporting date
16 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .